© 2023 91.9 KVCR

KVCR is a service of the San Bernardino Community College District.

San Bernardino Community College District does not discriminate on the basis of age, color, creed, religion, disability, marital status, veteran status, national origin, race, sex, sexual orientation, gender identity or gender expression.

701 S Mt Vernon Avenue, San Bernardino CA 92410
909-384-4444
Where you learn something new every day.
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Developing New Drugs for Infectious Disease

A man infected with extensively drug-resistant tuberculosis remains in isolation in a Denver hospital, preparing to undergo surgery to treat his illness. One of his doctors discusses plans for treating him, his prognosis, and the state of new drug development for infectious diseases.

Dr. Michael Iseman, former chief, Tuberculosis Program, National Jewish Medical and Research Center; professor of medicine, Divisions of Pulmonary Medicine and Infectious Diseases, University of Colorado

Michael Draper, director, Anti-Infective Drug Discovery, Paratek Pharmaceuticals

Scott Franzblau, professor, Department of Medicinal Chemistry and Pharmacognosy; director, Institute for Tuberculosis Research, University of Illinois at Chicago

Copyright 2023 NPR. To see more, visit https://www.npr.org.